View in EDS

Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.

Saved in:
Bibliographic Details
Title: Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Authors: Stein, Cy A.1, Levin, Richard2, Given, Robert3, Higano, Celestia S.4, Nemeth, Paul5 pnemeth@churchillpharma.com, Bosch, Bill5, Chapas-Reed, Jillian5, Dreicer, Robert6
Source: Urologic Oncology. Feb2018, Vol. 36 Issue 2, p81.e9-81.e16. 1p.
Database: Academic Search Ultimate
Description
ISSN:10781439
DOI:10.1016/j.urolonc.2017.10.018